Home > Riviste > Italian Journal of Vascular and Endovascular Surgery > Fascicoli precedenti > Italian Journal of Vascular and Endovascular Surgery 2021 December;28(4) > Italian Journal of Vascular and Endovascular Surgery 2021 December;28(4):105-12

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   

Italian Journal of Vascular and Endovascular Surgery 2021 December;28(4):105-12

DOI: 10.23736/S1824-4777.21.01508-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

A ten-year experience of thrombolysis for lower limb ileo-femoral DVTs

Emily N. KIRKHAM 1, 2 , Guy HICKSON 2, 3, Raymond RAMNARINE 2, 3, David G. COOPER 1, 2

1 Vascular Department, Gloucestershire Royal Hospital, Gloucester, UK; 2 Gloucester Hospitals NHS Foundation Trust, Gloucester, UK; 3 Department of Interventional Radiology, Gloucestershire Royal Hospital, Gloucester, UK



BACKGROUND: Catheter-directed thrombolysis (CDT) for deep vein thrombosis (DVT) can reduce rates of post-thrombotic syndrome (PTS). We report our experience with CDT.
METHODS: Consecutive patients undergoing CDT for acute proximal lower-limb DVTs from 2009-2019 were recruited. Eligibility criteria were utilized to decide a patient’s fitness for CDT. Patient demographics, complications of CDT and post-CDT stenting outcomes were collected. The Villalta Score was collected by telephone consultation between May-July 2019.
RESULTS: Thirty-seven patients were thrombolyzed. Median follow-up was 63 months (12-115 months). Mean age was 48 (18-75). Fourteen patients had May-Thurner Syndrome. There was one death following CDT; secondary to multi-organ failure from chemotherapy for acute myeloid leukemia. No other immediate complications of CDT occurred. Fourteen patients (37.8%) had venous stenting; stents were patent in all initial duplex scans. Twenty-eight patients were contactable; the median Villalta Score was 0 (range 0-15, N.=2 score >5). Only two patients (7.1%) developed PTS.
CONCLUSIONS: Our CDT burden for lower-limb DVTs is low. However, long-term outcomes are good, with only 7.1% developing PTS, suggesting cautious use of CDT with selective stenting in an appropriate population can produce satisfactory short- and longer-term outcomes. In light of conflicting evidence and more recent developments in technology, the long-term benefit of intervention for iliofemoral DVT over traditional conservative management warrants further investigation.


KEY WORDS: Venous thrombosis; Thrombolytic therapy; Post-thrombotic syndrome

inizio pagina